Dabur expects low-single-digit Q1 FY26 growth due to weak beverage sales; HPC and healthcare categories drive gains. Outlook positive on macro recovery.

Dabur India confident of FY26 recovery, driven by monsoon, macro factors Dabur India expects a revival in consumption by FY26, driven by a normal monsoon, easing inflation, and rising government ...

In a fresh setback to yoga guru Ramdev, the Delhi High Court on Thursday restrained his Patanjali Ayurved from running allegedly disparaging advertisements against Dabur Chyawanprash.

Dabur expects low single-digit Q1 FY26 revenue growth; Home and Personal Care and healthcare segments lead, while beverages see a dip due to unseasonal rains.

Delhi HC orders Patanjali to stop 'misleading' ads about Dabur Chyawanprash Dabur, had in December, gone to court claiming that Patanjali’s ads were hurting its reputation and misleading people.

Dabur Nepal has promoted Dabur Chyawanprash as an effective Ayurvedic health supplement for the monsoon season, emphasizing its role in enhancing immunity and protecting the body against seasonal ...

The Delhi High Court has passed an interim order directing Patanjali Ayurved to take down advertisements allegedly disparaging Dabur’s Chyawanprash product, as per media reports.

Dividend Stocks: Several companies, including Tata Consultancy Services and Bharti Airtel, will trade ex-dividend from July 14 to 18, according to BSE.

The Delhi High Court has restrained Patanjali from running disparaging advertisements against Dabur Chyawanprash, following a plea by Dabur alleging that Patanjali's ads were disparaging their ...

The Delhi high court on Thursday restrained Patanjali Ayurved from running allegedly disparaging advertisements against consumer giant Dabur’s Chawanprash. Dabur moved the court seeking to ...

Dabur India shares surge 3.79% amid high volume in morning session Boosted by high volume trading, Dabur India reflects a notable intraday gain on the Nifty Next 50.